Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population

• DOI: 10.1371/journal.pone.0139197
• Publication Date: 2015-09-25T18:25:49Z
• Authors: Agnieszka Paziewska; Bozena Cukrowska; Michalina Dabrowska; Krzysztof Goryca; Magdalena Piatkowska; Anna Kluska; Michal Mikula; Jakub Karczmarski; Beata Oralewska; Anna Rybak; Jerzy Socha; Aneta Balabas; Natalia Zeber-Lub...; Filip Ambrozkiewicz; Ewa Konopka; Ilona Trojanowska; Malgorzata Zagroba; Malgorzata Szperl; Jerzy Ostrowski
• Keywords: Adult; Male; 0301 basic medicine; 2. Zero hunger; 0303 health sciences; Adolescent; Science; Q; R; Cell Cycle Proteins; Polymorphism, Single Nucleotide; Sensitivity and Specificity; 3. Good health; Celiac Disease; 03 medical and health sciences; Haplotypes; HLA Antigens; Case-Control Studies; Medicine; Humans; Female; Genetic Testing; Poland; Child; Research Article

Assessment of non-HLA variants alongside standard HLA testing was previously shown to improve the identification of potential coeliac disease (CD) patients. We intended to identify new genetic variants associated with CD in the Polish population that would improve CD risk prediction when used alongside HLA haplotype analysis. DNA samples of 336 CD and 264 unrelated healthy controls were used to create DNA pools for a genome wide association study (GWAS). GWAS findings were validated with individual HLA tag single nucleotide polymorphism (SNP) typing of 473 patients and 714 healthy controls. Association analysis using four HLA-tagging SNPs showed that, as was found in other populations, positive predicting genotypes (HLA-DQ2.5/DQ2.5, HLA-DQ2.5/DQ2.2, and HLA-DQ2.5/DQ8) were found at higher frequencies in CD patients than in healthy control individuals in the Polish population. Both CD-associated SNPs discovered by GWAS were found in the CD susceptibility region, confirming the previously-determined association of the major histocompatibility (MHC) region with CD pathogenesis. The two most significant SNPs from the GWAS were rs9272346 (HLA-dependent; localized within 1 Kb of DQA1) and rs3130484 (HLA-independent; mapped to MSH5). Specificity of CD prediction using the four HLA-tagging SNPs achieved 92.9%, but sensitivity was only 45.5%. However, when a testing combination of the HLA-tagging SNPs and the MSH5 SNP was used, specificity decreased to 80%, and sensitivity increased to 74%. This study confirmed that improvement of CD risk prediction sensitivity could be achieved by including non-HLA SNPs alongside HLA SNPs in genetic testing.